Skip to main content
. 2020 Apr 27;28:100519. doi: 10.1016/j.ijcha.2020.100519

Fig. 3.

Fig. 3

Integrated 18F-Flutemetamol PET/MRI in a patient with ATTRv-CA. The patient had known ATTRv with polyneuropathy under treatment with tafamidis and presented with new onset dyspnea. T1 mapping revealed prolongation of relaxation time (A). Subendocardial late gadolinium enhancement was present (B). PET images showed 18F-Flutemetamol uptake of the left and right ventricle, indicative of advanced stage myocardial amyloid infiltration (C).